Benzyl Alcohol in Neuromuscular Blocking Agents
Autor: | ANDRE L. VAN DER HAL, HUGH M. MACDONALD, LAURENCE SHAW, SUKSHMA SREEPATHI, SCOTT A. BEASLEY |
---|---|
Rok vydání: | 1987 |
Předmět: | |
Zdroj: | Pediatrics. 79:841-842 |
ISSN: | 1098-4275 0031-4005 |
DOI: | 10.1542/peds.79.5.841a |
Popis: | To the Editor.— Recent letters to the Editors1,2 suggested discontinuation of clinical trials with doxapram for apnea of prematurity, because the preparation contains the preservative benzyl alcohol, implicated as the cause for the gasping syndrome at doses of 94 to 245 mg/kg/d.3 After we reexamined our standard arsenal of drugs used in the neonatal intensive care unit, we found an additional class of drugs containing benzyl alcohol: neuromuscular blocking agents. Pancuronium bromide (Pavulon, [Organon]) is prepared in 1-mg/mL vials containing 1% (10 mg/mL) benzyl alcohol. |
Databáze: | OpenAIRE |
Externí odkaz: |